Review: less than maximum doses of ACE inhibitors lower BP to near maximum levels in hypertension

Affiliations

Comment

David L Bronson. Evid Based Med. 2009 Apr.

. 2009 Apr;14(2):49.

doi: 10.1136/ebm.14.2.49.

No abstract available

Comment on

Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension.
Heran BS, Wong MM, Heran IK, Wright JM. Heran BS, et al. Cochrane Database Syst Rev. 2008 Oct 8;2008(4):CD003823. doi: 10.1002/14651858.CD003823.pub2. Cochrane Database Syst Rev. 2008. PMID: 18843651 Free PMC article.

Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy.
Deedwania PC. Deedwania PC. Cardiol Clin. 2005 May;23(2):139-52. doi: 10.1016/j.ccl.2004.06.006. Cardiol Clin. 2005. PMID: 15694743 Review.
Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
Karlberg BE, Fyhrquist F, Grönhagen-Riska C, Tikkanen I, Ohman KP. Karlberg BE, et al. Scand J Urol Nephrol Suppl. 1984;79:103-6. Scand J Urol Nephrol Suppl. 1984. PMID: 6089307 Clinical Trial.
Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR. Weir MR. Clin Ther. 2007 Sep;29(9):1803-24. doi: 10.1016/j.clinthera.2007.09.019. Clin Ther. 2007. PMID: 18035185 Review.
[Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL. Qiu YG, et al. Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Aug;25(8):710-4. Zhonghua Liu Xing Bing Xue Za Zhi. 2004. PMID: 15555399 Chinese.
Control of hypertension in children after renal transplantation.
Seeman T, Simková E, Kreisinger J, Vondrák K, Dusek J, Gilík J, Feber J, Dvorák P, Janda J. Seeman T, et al. Pediatr Transplant. 2006 May;10(3):316-22. doi: 10.1111/j.1399-3046.2005.00468.x. Pediatr Transplant. 2006. PMID: 16677355